Services
Growth Innovation Operations
Cases
Insights
AGP Insights Eco Insiders Podcast
About
Contact
EN
中文

Personal Information

Upload Avatar (500 x 500)
Ying Wang
wangy98@smu.edu.cn
Chinese, English
Guangdong

Academic Information

Southern Medical University
Basic Medical Sciences
  • 2009 - PhD in Organic Chemistry: Hunan University
  • 2008 - Visiting Scholar: Emory University
  • Published 23 SCI papers as first or corresponding author
  • Granted 6 national invention patents
  • 2010-present - Southern Medical University, Institute of Cancer Research - Associate Researcher
  • 2017: First Prize in Pharmaceutical Science and Technology by Guangdong Pharmaceutical Association
  • 2020: Second Prize in Natural Science by Guangdong Science and Technology Award

Research

Biomimetic drug delivery systems for cancer treatment
  • Self-anti-angiogenesis nanoparticles enhance anti-metastatic-tumor efficacy of chemotherapeutics., Jiamao Luo, Xinxian Zhong, Yingming Peng, Chenyuan Hao, Xiaomei Liang, Yulu Yang, Xiubo Shi, Xuncai Chen, Xiao Yi, Xiaoxuan Li, Jianhua Wu, Jinheng Li, Qian Xiao, Chentian Wu, Ruojing Lu, Yao Pan, Xuejiao Wang, Jun-Bing Fan*, Yifeng Wang*, Ying Wang*, 2022
  • Lemon-Derived Extracellular Vesicles Nanodrugs Enable Efficiently Overcome Cancer Multidrug Resistance by Endocytosis-Triggered Energy Dissipation and Energy Production Reduction., Qian Xiao, Wei Zhao, Chentian Wu, Xuejiao Wang, Jianping Chen, Xiubo Shi, Suinan Sha, Jinheng Li, Xiaomei Liang, Yulu Yang, Yingming Peng, Haoyan Guo, Ying Wang*, Jun-Bing Fan*, 2022
  • A biomimetic drug delivery system by integrating grapefruit extracellular vesicles and doxorubicin-loaded heparin-based nanoparticles for glioma therapy., Wenbo Niu, Qian Xiao, Xuejiao Wang, Junqiao Zhu, Jinheng Li, Xiaomei Liang, Yingming Peng, Chentian Wu, Ruojing Lu, Yao Pan, Jiamao Luo, Xinxian Zhong, Haoqi He, Zhili Rong, Jun-Bing Fan*, Ying Wang*, 2021
  • Response of pH-sensitive Doxorubicin nanoparticles on complex tumor microenvironments by tailoring multiple physicochemical properties., Huajian Chen#, Qizhi Luo#, Jihui Wang#, Haoqi He, Wanxian Luo, Li Zhang, Qian Xiao, Taoliang Chen, Xiangdong Xu, Wenbo Niu, Yiquan Ke*, Ying Wang*, 2020
  • An acoustic/thermo-responsive hybrid system for advanced doxorubicin delivery in tumor treatment., Li Zhang#, Shiyu Zhang#, Huajian Chen, Yu Liang, Bingxia Zhao, Wanxian Luo, Qian Xiao, Jinheng Li, Junqiao Zhu, Chao Peng, Yaru Zhang, Zhe Hong, Ying Wang*, Yingjia Li*, 2020
  • cRGD-functionalized nanoparticles for combination therapy of anti-endothelium dependent vessels and anti-vasculogenic mimicry to inhibit the proliferation of ovarian cancer., Yifeng Wang #, Lin Tong #, Jianguo Wang, Jiamao Luo, Jiao Tang, Lijuan Zhong, Qian Xiao , Wenbo Niu, Jinheng Li, Junqiao Zhu, Huajian Chen, Xin Li*, Ying Wang*, 2019
  • Dual-targeted and pH-sensitive Doxorubicin Prodrug-Microbubble Complex with Ultrasound for Tumor Treatment., Wanxian Luo, Ge Wen, Li Yang, Jiao Tang, Jianguo Wang, Jihui Wang, Shiyu Zhang, Li Zhang, Fei Ma, Liling Xiao, Ying Wang*, Yingjia Li*, 2017
  • Synergistic effects of negative-charged nanoparticles assisted by ultrasound on the reversal multidrug resistance phenotype in breast cancer cells., Dongxiao Wang, Wanxian Luo, Ge Wen, Li Yang, Shaofu Hong, Shiyu Zhang, Jianxin Diao, Jianguo Wang, Hongqin Wei, Yingjia Li*, Ying Wang*, 2017
  • Dual-Targeting and Reself-Assembly Heparin-Based Nanoparticles for Combining Anti-Proliferation and Anti-Angiogenesis Therapy of Glioma., Jihui Wang, Yuantao Yang, Yonghong Zhang, Min Huang, Zhenjun Zhou, Wanxian Luo, Jiao Tang, Jianguo Wang, Qian Xiao, Huajian Chen, Yingqian Cai, Xinlin Sun*, Ying Wang*, Yiquan Ke*, 2016
  • Response of heterogeneous cancer cells on targeted nanoparticles., Ying Wang*, Yingjia Li, Dongxiao Wang, Shaofu Hong, Jianguo Wang, Baoping Xie, Qianbing Zhang, Xingmei Zhang, Hongfen Shen, Qian Xiao, 2016
Keywords
Biomimetic Drug Delivery Cancer Ovarian Cancer Glioma Breast Cancer Extracellular Vesicles Therapeutics Nanoparticles Pharmacokinetics
Related Professors
Genze Shao - Peking University
Area of Focus
Brca1 | Tumor Suppressor | Gene | Breast Cancer | Ovarian Cancer | Dna Damage | Cell Cycle | Molecular Mechanisms | Protein Degradation | Cancer Research | Metastasis | K63 Ubiquitination | Chromatin Remodeling | Epigenetics | Rnf8 | Tumor Progression | Molecular Biology | Cancer Therapy | Protein Interactions | Biomarkers | Early Diagnosis | Therapeutic Evaluation | Prognosis | Serum Markers | Tumor Specific | Sensitive Markers | Cancer Detection | Clinical Applications | Molecular Diagnostics | Cell Division | Mitosis | Spindle Assembly | Checkpoint Mechanisms | Protein Ubiquitination | Deubiquitinating Enzymes | Genetic Stability
Wenhua Yu - Peking University
Area of Focus
Metabolism | Tumor | Cancer | Epigenetics | Histone | Deacetylation | Sirt7 | Pancreatic Cancer | Breast Cancer | Pathophysiology
Yingying Xu - Fudan University
Area of Focus
Cell Polarity | Cancer | Tumor | Metabolism | Biochemistry | Molecular Biology | Glycosyltransferase | Cell Behavior | Apoptosis | Breast Cancer
View All
© 2015-2024 Asia Growth Partners Limited | Privacy Policy

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.